Chemotherapy and Radiotherapy utilize DNA-PK and PARP inhibitors to sensitize cancer cells, however these inhibitors have so far only been limited to homologous recombination repair deficient tumors, exploiting synthetic lethality. In the study “Sensitizing ewing...
Since October 2017, the radiation clinic and MVZ radiotherapy at the Sana Klinikum Offenbach have a new orthovolt device for X-ray irradiation. "We are pleased to be able to offer our patients another treatment option with the new device," explains chief physician...
January 31st, 2018 – Xstrahl, the leader in X-Ray Technology for treatment of Superficial Skin conditions is pleased to offer the new RADiant therapy system to Physician’s in America. Representing the next generation of compact radiotherapy systems, RADiant’s dual...
Radiation therapy has proven to be an efficient and effective second line option for the treatment of Basal Cell and Squamous Cell Carcinomas, used in special circumstances, such as when surgical intervention is contraindicated or patient scarring concerns. Melanomas...
Combined radiotherapy and hyperthermia offer great potential for the successful treatment of radio-resistant tumours through thermo-radiosensitization. Tumour response heterogeneity, due to intrinsic, or micro-environmentally induced factors, may greatly influence...
Outside of getting excited about playoff hockey and snowboard trips out west, I also find myself enthusiastic about studies/efforts in cancer biology that push the boundaries to further characterize pre-clinical cancer models in a clinical way. The study presented in...
Throughout the last 100 years, numerous milestones in the study and treatment of cancer have been achieved. Discoveries like combination chemotherapy, correlation of smoking and lung cancer, HPV and cervical carcinogenesis, BRCA-1&2 gene inheritance and breast...
January 10th, 2018 – Xstrahl today released an upgrade to its Concerto software streamlining the clinical workflow for the entire range of the Xstrahl systems. Concerto 2.0 provides a streamlined workflow, enhanced connectivity options and a treatment verification...
January 4th, 2018 – The Xstrahl Group officially announced that Adrian Treverton has been promoted to Group CEO. This comes as the previous CEO, Martin Robinson retired in the new year after working for the company nearly 20 years. Adrian had more than 10 years of...
Contact Us